Granuflo and Naturalyte claims information, FDA Issues advisement

The FDA has advised health care professionals and patients that GranuFlo and NaturaLyte products when inappropriately prescribed or administered in dosing errors may cause life-threatening cardiac problems. “This may contribute to metabolic alkalosis, which is a significant risk factor associated with low blood pressure, hypokalemia, hypoxemia, hypercapnia and cardiac arrhythmia, which, if not appropriately treated, may culminate in cardiopulmonary arrest,” the FDA said in its announcement. “This product may cause serious adverse health consequences, including death.”

If you have been treated with these drugs, please contact Rebecca or Shane Langston at Langston and Langston PLLC. 1 (888) 329-0827,,

Leave a Reply